EIRNA BIO LIMITED

EIRNA BIO Limited is a specialist life‑science company dedicated to advancing translational biology through the power of translatomics. By delivering the deepest insights into protein synthesis, the firm helps RNA researchers turn raw data into smarter discoveries, accelerating drug and biomarker development across disease areas such as cancer, neurodegeneration and metabolic disorders.

The core service portfolio includes high‑resolution ribosome profiling and tRNA‑Seq, complemented by a suite of proprietary platforms. EIRNABio Connect is a secure, browser‑based analytics environment that lets scientists explore and visualise their data in real time. cMAST enables high‑throughput screening of translation under a multitude of experimental conditions, while the Translon Explorer platform uncovers previously hidden small peptides with significant biological functions. Together, these tools provide a comprehensive, “beyond‑cookie‑cutter” approach to translatomics that fuels both academic and commercial research.

EIRNA BIO serves a global community of RNA scientists, pharmaceutical developers and academic collaborators, offering unrivalled expertise and impactful partnerships that translate deeper molecular insight into tangible scientific progress.